1 in 2 diabetics suffer from Peripheral Neuropathy[1] during their lifetime
P&G Health, makers of Neurobion, embark on an effort to help people 'Put Life Back in Their Hands' for an improved quality of life. Launched on World Diabetes Day across 18 countries, the campaign raises awareness on Peripheral Neuropathy in diabetes, and the importance of early identification and timely treatment. SINGAPORE, Nov. 8, 2022 /PRNewswire/...
HARBOUR BIOMED LAUNCHES NONA BIOSCIENCES’ “IDEAS TO IND” PRECLINICAL SOLUTIONS BUSINESS TO ACCELERATE GLOBAL BIOTHERAPEUTIC INNOVATION
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 15, 2022 /PRNewswire/ -- Harbor BioMed (HKEX: 02142) today announced establishment of a wholly-owned subsidiary, Nona Biosciences, to provide next-generation antibody and biotherapeutic solutions to partners from discovery to IND. The new subsidiary will leverage Harbour BioMed's technology platforms, including its Harbour Mice® and...
Live from ASH 2022 | Ascentage Pharma Presents Latest Data of APG-2575, Including Encouraging Results of the Combination with BTKi in Patients with R/R CLL/SLL
SUZHOU, China and ROCKVILLE, Md. , Dec. 13, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released preliminary results from a global Phase II study of lisaftoclax (APG-2575), a key member of the...
Gift of Life Donor Program: Nation’s Leader for 15 Years
Gift of Life Staff, Community & Hospital Partners Continue Proud History of Saving Lives Together PHILADELPHIA, Jan. 9, 2023 /PRNewswire/ -- Gift of Life Donor Program continues to lead the U.S. in life-saving organ donations for a milestone 15 consecutive years thanks to its dedicated staff, hospital partners and generous community. In 2022,...
CGTN: TCM continues to play significant role in treating COVID-19
BEIJING, Jan. 11, 2023 /PRNewswire/ -- Traditional Chinese Medicine (TCM) has been playing an important role in China's fight against COVID-19. As China is shifting the focus of its COVID-19 response from preventing infections to protecting people's health and preventing severe cases, the unique strength of TCM is further leveraged by health authorities to protect the life and health...
AMCOR EXPANDS HEALTHCARE PLATFORM IN THE ASIA PACIFIC REGION WITH ACQUISITION OF MDK
Complementary capabilities, product offering, and customer base solidifies leadership position in priority high growth medical device packaging segment ZURICH, Jan. 17, 2023 /PRNewswire/ -- Amcor (NYSE: AMCR) (ASX:AMC), a global leader in developing and producing responsible packaging solutions, today announced it has entered into an agreement to acquire Shanghai-based MDK. MDK generates annual sales of approximately $50 million...
GenScript ProBio Congratulates Eutilex’s IND Clearance from MFDS
NANJING, China, March 7, 2023 /PRNewswire/ -- Recently, Eutilex, a partner of GenScript ProBio, announced MFDS (Ministry of Food and Drug Safety) clearance of its hepatocellular carcinoma clinical trial application for innovative CAR-T program (EU307). GenScript ProBio extends congratulations on this. 2 years ago, GenScript ProBio and Eutilex announced that the parties entered...
Origin Agritech GMO Corn Hybrid is the One and Only Triple Stack Trait Corn Selected for National Demo Plot, Being Grown There in Anticipation of 2023 Commercial Launch
BEIJING, April 11, 2023 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), announced today that its GMO corn hybrid is the one and only triple stacked trait corn selected for the national demo plot and is currently being grown there in anticipation of a 2023 commercial launch. The hybrid has the approved triple stack traits BFL4-2,...
BIOMERICS EXPANDS MANUFACTURING OPERATIONS IN TEXAS
SALT LAKE CITY, April 14, 2023 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the completion of a 24,000 sq. ft. expansion of manufacturing operations at their Athens, TX, facility. Driven by growth in the single-use endoscopy market, this investment includes 8,500 sq....
Bactiguard Holding AB’s report for the first quarter 2023
Continued focus on growth and transformation STOCKHOLM, April 27, 2023 /PRNewswire/ -- First quarter 2023, January-March Revenues amounted to SEK 61.2 (55.2) million, an increase of 11%. Adjusted for currency effects, revenues decreased by 4%. Operating loss amounted to SEK 18.7 (16.6) million, an increase of SEK 2.1 million. EBITDA amounted to SEK -6.6 (-4.0) million, with an...
